• 12 Hits
  • Search Condition : Filter (MeSH = Antibodies, Viral)
Species Resource Title
Human pathogenic viruses SARS-CoV-2 Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination
Human pathogenic viruses DENV-1 , DENV-2 , DENV-4 Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data
Human pathogenic viruses SARS-CoV-2 Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam
Human pathogenic viruses CHIKV S-27 strain (African prototype) Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017–2019
Human pathogenic viruses 99St12A , 00st22A , SLMC50 , SLMC318 Epidemiological evidence of acute transmission of Zika virus infection in dengue suspected patients in Sri-Lanka
Human pathogenic viruses Clinical, Virological, and Immunological Features in Cosmopolitan Genotype DENV-2–Infected Patients during a Large Dengue Outbreak in Sri Lanka in 2017
Human pathogenic viruses Burden of Chikungunya Virus Infection during an Outbreak in Myanmar
Silkworms SARS-CoV-2 strain-specific anti-spike IgG ELISA utilizing spike protein produced by silkworms.
Human and Animal Cells MA104(RCB0994) Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein.
Silkworms d17 High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity.
Silkworms Eri silkworm The potential of a universal influenza virus-like particle vaccine expressing a chimeric cytokine.
Human and Animal Cells NIH3T3 A single immunization with cellular vaccine confers dual protection against SARS-CoV-2 and cancer.